2,6-Diphenyl-4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine, 97%, 1g

4-methyl-2-(3-piperidinyl)-1H-benzimidazole dihydrochloride, 95.0%, 10g

Mono[tris(hydroxymethyl)aminomethane]phosphate, 99.0%, 100g

2-(2-((6-Chlorohexyl)oxy)ethoxy)ethan-1-ol, 95%, 100mg

1,1'-Di-n-octyl-4,4'-bipyridinium Dibromide, >98.0%(HPLC)(T), 10g

2-(4-Cyclopropylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

1-Bromo-2-(methoxymethyl)naphthalene, 98%, 1g

Lucitanib, 98.94%, 10mg

[1,1'-Biphenyl]-4-acetic acid, 4'-[3-methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl]-, 250mg

N-Benzyl-N'-boc-ethylenediamine, 95.0%, 10g

2,2,2-Trifluoro-N-[3-(trifluoroacetamido)phenyl]-acetamide, 1g

Piperonyl Acetate>98.0%(GC)25g

3-Bromo-5-fluorotoluene, 98.0%, 1g